glp 1 drugs for prediabetes Do The Benefits of GLP-1 OutWeigh the Negatives? GLP-1 Costs Explained: Managing Coverage

In a 68-week placebo-controlled trial, once-weekly semaglutide (Ozempic, Wegovy) injections in people with obesity and moderate knee osteoarthritis produced significantly greater reductions in body weight along with significant improvements in pain scores and better physical function

adults have obesity, according to the federal Centers for Disease Control and Prevention

Online platforms offer ease of access to medications, often at competitive pricing, while ensuring privacy, an appealing feature for patients managing chronic conditions such as diabetes or obesity

Clinical Implications: How to Translate This in Practice For endocrinologists and metabolic specialists, the message is clear

31 Over the past 20 years, new GLP-1RAs with extended half-lives have proven to be highly effective treatments for T2D and even weight loss

Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine